As shown in Figure 2, the rates of AE were not statistically significant different according to the type of biologic (mean rate: 11.3 (95% CI 9.9–12.7)/100 PY; p = 0.11) in elderly IBD patients treated with anti-TNF, VDZ and/or UST. This evidence concerns the gene TNF and inflammatory bowel disease.